Speed to market won't guarantee success in today's launch environment. Anticipating what prescribers, patients and payers will value is key, according to experts at EY.
Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.
Atropisomers are key to modern small molecule drug development. Learn how advanced manufacturing strategies enable the isolation and scalable production of the most effective single isomer.
Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.
